The pharmaco-economics of peri-operative statin therapy.
Where this comes from
- Record sourced from PubMed, PMID 16229688.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We analysed the pharmaco-economics of the prospective peri-operative studies of statin administration for major elective vascular surgery, using the NHS reference costs for 2004. This analysis suggests that peri-operative statin therapy for patients undergoing vascular surgery may present the most cost-effective use of statin therapy yet described, with a number-needed-to-treat of 15 and almost 60% of the total cost of atorvastatin therapy recovered through a reduction in peri-operative adverse events.
Medical subject headings
- Cardiovascular Diseases
- Heptanoic Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Perioperative Care
- Pyrroles
- Vascular Surgical Procedures